Literature DB >> 9038599

Chemotherapy of high-grade gliomas: beginning of a new era or the end of the old?

M Brada, G Sharpe.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 9038599     DOI： 10.1016/s0959-8049(96)00400-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  5 in total

1.  Thallium-201 SPECT as response parameter for PCV chemotherapy in recurrent glioma.

Authors:  M F Roesdi; T J Postma; O S Hoekstra; C J van Groeningen; J G Wolbers; J J Heimans
Journal:  J Neurooncol       Date:  1998-12       Impact factor: 4.130

2.  Gossypol treatment of recurrent adult malignant gliomas.

Authors:  P Bushunow; M M Reidenberg; J Wasenko; J Winfield; B Lorenzo; S Lemke; B Himpler; R Corona; T Coyle
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

3.  Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods.

Authors:  Evanthia Galanis; Jan C Buckner; Matthew J Maurer; Rene Sykora; René Castillo; Karla V Ballman; Bradley J Erickson
Journal:  Neuro Oncol       Date:  2006-03-02       Impact factor: 12.300

4.  Review of microdialysis in brain tumors, from concept to application: first annual Carolyn Frye-Halloran symposium.

Authors:  Ramsis K Benjamin; Fred H Hochberg; Elizabeth Fox; Peter M Bungay; William F Elmquist; Clinton F Stewart; James M Gallo; Jerry M Collins; Robert P Pelletier; John F de Groot; Robert C Hickner; Idil Cavus; Stuart A Grossman; O Michael Colvin
Journal:  Neuro Oncol       Date:  2004-01       Impact factor: 12.300

Review 5.  Chemotherapy for high-grade gliomas.

Authors:  E Galanis; J Buckner
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.